Chehab, Omar
Akl, Elie
Abdollahi, Ashkan
Zeitoun, Ralph
Ambale-Venkatesh, Bharath
Wu, Colin
Tracy, Russell
Blumenthal, Roger S.
Post, Wendy S.
Lima, Joao A. C.
Rodriguez, Annabelle
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (N01-HC-95159, N01-HC- 95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169)
National Center for Research Resources National Institutes of Health Intramural Research Program (UL1-TR-000040, UL1-TR-001079)
Bayer Healthcare for the use of gadolinium contrast agent
Article History
Received: 26 August 2023
Accepted: 6 November 2023
First Online: 17 November 2023
Competing interests
: A.R. reports inventorship rights to patents held by the University of Connecticut Health and Lipid Genomics. A.R. is the founder of Lipid Genomics. The remaining authors declare no competing interests.